Abstract
The skin of patients with atopic dermatitis (AD) has a unique predisposition for colonization by Staphylococcus aureus (S. aureus), which contributes to the inflammation and grim prognosis of AD. Although the mechanism underlying the S. aureus-induced exacerbation of AD remains unclear, recent studies have found a pivotal role for pattern recognition receptors in regulating the inflammatory responses in S. aureus infection. In the present study, we used a typical mouse model of AD-like skin inflammation and found that S. aureus-associated nucleotide-binding oligomerization domain-containing protein 2 (NOD2) and toll-like receptor 2 (TLR2) ligands exacerbated AD-like symptoms, which were further deteriorated by the in vivo expansion of basophils and eosinophils. Subsequent histological analyses revealed that dermal fibroblasts were pervasive in the AD-like skin lesions. Co-culture of human dermal fibroblasts with basophils and eosinophils resulted in a vigorous cytokine/chemokine response to the NOD2/TLR2 ligands and the enhanced expression of intercellular adhesion molecule-1 on the dermal fibroblasts. Basophils and eosinophils were primarily responsible for the AD-related cytokine/chemokine expression in the co-cultures. Direct intercellular contact was necessary for the crosstalk between basophils and dermal fibroblasts, while soluble mediators were sufficient to mediate the eosinophil–fibroblast interactions. Moreover, the intracellular p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and nuclear factor-kappa B signaling pathways were essential for NOD2/TLR2 ligand-mediated activation of basophils, eosinophils, and dermal fibroblasts in AD-related inflammation. This study provides the evidence of NOD2/TLR2-mediated exacerbation of AD through activation of innate immune cells and therefore sheds light on a novel mechanistic pathway by which S. aureus contributes to the pathophysiology of AD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bieber T . Atopic dermatitis. N Engl J Med 2008; 358: 1483–1494.
Sicherer SH, Leung DY . Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2013. J Allergy Clin Immunol 2014; 133: 324–334.
Boguniewicz M, Leung DY . Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242: 233–246.
Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS . Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009; 123: e808–e814.
Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol 2006; 155: 680–687.
Matsui K, Wirotesangthong M, Nishikawa A . Percutaneous application of peptidoglycan from Staphylococcus aureus induces eosinophil infiltration in mouse skin. Clin Exp Allergy 2007; 37: 615–622.
Travers JB, Kozman A, Mousdicas N, Saha C, Landis M, Al-Hassani M et al. Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid. J Allergy Clin Immunol 2010; 125: 146–152.
Takeuchi O, Akira S . Pattern recognition receptors and inflammation. Cell 2010; 140: 805–820.
Hruz P, Zinkernagel AS, Jenikova G, Botwin GJ, Hugot JP, Karin M et al. NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation. Proc Natl Acad Sci USA 2009; 106: 12873–12878.
Kuo IH, Carpenter-Mendini A, Yoshida T, McGirt LY, Ivanov AI, Barnes KC et al. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol 2013; 133: 988–998.
Niebuhr M, Baumert K, Werfel T . TLR-2-mediated cytokine and chemokine secretion in human keratinocytes. Exp Dermatol 2010; 19: 873–877.
Takeuchi O, Hoshino K, Akira S . Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000; 165: 5392–5396.
Kaesler S, Volz T, Skabytska Y, Koberle M, Hein U, Chen KM et al. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10. J Allergy Clin Immunol 2014; 134: 92–99.
Bieneman AP, Chichester KL, Chen YH, Schroeder JT . Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE-independent secretion. J Allergy Clin Immunol 2005; 115: 295–301.
Irani AM, Huang C, Xia HZ, Kepley C, Nafie A, Fouda ED et al. Immunohistochemical detection of human basophils in late-phase skin reactions. J Allergy Clin Immunol 1998; 101: 354–362.
Simon D, Braathen LR, Simon HU . Eosinophils and atopic dermatitis. Allergy 2004; 59: 561–570.
Karasuyama H, Mukai K, Obata K, Tsujimura Y, Wada T . Nonredundant roles of basophils in immunity. Annu Rev Immunol 2011; 29: 45–69.
Stone KD, Prussin C, Metcalfe DD . IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2010; 125: S73–S80.
Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008; 38: 709–750.
Komiya A, Nagase H, Okugawa S, Ota Y, Suzukawa M, Kawakami A et al. Expression and function of toll-like receptors in human basophils. Int Arch Allergy Immunol 2006; 140: 23–27.
Wong CK, Cheung PF, Ip WK, Lam CW . Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol 2007; 37: 85–96.
Qiu HN, Wong CK, Chu IM, Hu S, Lam CW . Muramyl dipeptide mediated activation of human bronchial epithelial cells interacting with basophils: a novel mechanism of airway inflammation. Clin Exp Immunol 2013; 172: 81–94.
Wong CK, Hu S, Leung KM, Dong J, He L, Chu YJ et al. NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma. Cell Mol Immunol 2013; 10: 317–329.
Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P . Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci USA 2006; 103: 11736–11741.
Choi J, Kim JR, Kim H, Kim YA, Lee HJ, Kim J et al. The atopic dermatitis-like symptoms induced by MC903 were alleviated in JNK1 knockout mice. Toxicol Sci 2013; 136: 443–449.
Rebane A, Runnel T, Aab A, Maslovskaja J, Ruckert B, Zimmermann M et al. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J Allergy Clin Immunol 2014; 134: 836–847.
Ohmori K, Luo Y, Jia Y, Nishida J, Wang Z, Bunting KD et al. IL-3 induces basophil expansion in vivo by directing granulocyte-monocyte progenitors to differentiate into basophil lineage-restricted progenitors in the bone marrow and by increasing the number of basophil/mast cell progenitors in the spleen. J Immunol 2009; 182: 2835–2841.
Fischer AH, Jacobson KA, Rose J, Zeller R . Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc 2008; 2008: t4986.
Fukuda S, Midoro K, Kamei T, Gyoten M, Kawano Y, Ashida Y et al. Inhibition of allergic dermal inflammation by the novel imidazopyridazine derivative TAK-427 in a guinea pig experimental model of eczema. J Pharmacol Exp Ther 2002; 303: 1283–1290.
James JM, Kagey-Sobotka A, Sampson HA . Patients with severe atopic dermatitis have activated circulating basophils. J Allergy Clin Immunol 1993; 91: 1155–1162.
Jenerowicz D, Czarnecka-Operacz M, Silny W . Peripheral blood eosinophilia in atopic dermatitis. Acta Dermatovenerol Alp Pannonica Adriat 2007; 16: 47–52.
Lewis SA, Pavord ID, Stringer JR, Knox AJ, Weiss ST, Britton JR . The relation between peripheral blood leukocyte counts and respiratory symptoms, atopy, lung function, and airway responsiveness in adults. Chest 2001; 119: 105–114.
Wong CK, Leung KM, Qiu HN, Chow JY, Choi AO, Lam CW . Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis. PLoS One 2012; 7: e29815.
Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity 2015; 42: 756–766.
Sokol CL, Chu NQ, Yu S, Nish SA, Laufer TM, Medzhitov R . Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol 2009; 10: 713–720.
Khodoun MV, Orekhova T, Potter C, Morris S, Finkelman FD . Basophils initiate IL-4 production during a memory T-dependent response. J Exp Med 2004; 200: 857–870.
Finkelman FD, Madden KB, Morris SC, Holmes JM, Boiani N, Katona IM et al. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J Immunol 1993; 151: 1235–1244.
Lantz CS, Boesiger J, Song CH, Mach N, Kobayashi T, Mulligan RC et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998; 392: 90–93.
Nakashima C, Otsuka A, Kitoh A, Honda T, Egawa G, Nakajima S et al. Basophils regulate the recruitment of eosinophils in a murine model of irritant contact dermatitis. J Allergy Clin Immunol 2014; 134: 100–107.
Jeon JH, Kim SK, Baik JE, Kang SS, Yun CH, Chung DK et al. Lipoteichoic acid of Staphylococcus aureus enhances IL-6 expression in activated human basophils. Comp Immunol Microbiol Infect Dis 2012; 35: 363–374.
Acknowledgements
We thank James J. Lee from the Mayo Clinic (Scottsdale, AZ, USA) for providing us the rat anti-mouse MBP antibody. This work was supported by the Research Grant Committee General Research Fund, Hong Kong (project reference no.: CUHK 476813, principal investigator: CKW).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing commercial interests in relation to this work.
Additional information
Supplementary information of this article can be found on the Cellular & Molecular Immunology’s website (http://www.nature.com/cmi).
Supplementary information
Rights and permissions
About this article
Cite this article
Jiao, D., Wong, CK., Qiu, HN. et al. NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation. Cell Mol Immunol 13, 535–550 (2016). https://doi.org/10.1038/cmi.2015.77
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2015.77
Keywords
This article is cited by
-
Effect of Proinflammatory S100A9 Protein on Migration and Proliferation of Microglial Cells
Journal of Molecular Neuroscience (2023)
-
Network pharmacology and molecular docking-based prediction of active compounds and mechanisms of action of Cnidii Fructus in treating atopic dermatitis
BMC Complementary Medicine and Therapies (2022)
-
The influence of single nucleotide polymorphisms of NOD2 or CD14 on the risk of Mycobacterium tuberculosis diseases: a systematic review
Systematic Reviews (2021)
-
The pathogenic role of innate lymphoid cells in autoimmune-related and inflammatory skin diseases
Cellular & Molecular Immunology (2020)
-
Anti-IgE IgG autoantibodies isolated from therapeutic normal IgG intravenous immunoglobulin induce basophil activation
Cellular & Molecular Immunology (2020)